None listed
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
Queen Mary University of London
Eligibility
Inclusion criteria
Inclusion criteria: Participants who have not receive medication for type 2 diabetes Availability of genotype data Availability of stored venous blood samples
Exclusion criteria
Exclusion criteria: Individuals with self-reported diabetes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quantifying the diagnostic accuracy of adiponectin and leptin supports their potential integration into clinical screening tools and enhances our understanding of the biological mechanisms linking adipose tissue distribution to metabolic healthTimepoint: 1 year | — |
Secondary
| Measure | Time frame |
|---|---|
| Polygenic risk score developed for unfavourable fat distributionTimepoint: 1 year | — |
Countries
India
Contacts
Public ContactDr R Guha Pradeepa
Madras Diabetes Research Foundation Department of Research Operations and Diabetes Camplications
Outcome results
None listed